Bulk Pharmaceutical API Sources for FENTANYL HYDROCHLORIDE

Bulk Pharmaceutical API Sources for FENTANYL HYDROCHLORIDE

Vendor	Vendor Homepage	Vendor Sku	API Url
NovoSeek		83932
AAA Chemistry		AR-1J7185
ABI Chem		AC1L36GM

Fentanyl Hydrochloride Bulk API Sources

Last updated: February 19, 2026

This report identifies and analyzes key global suppliers of bulk Fentanyl Hydrochloride Active Pharmaceutical Ingredient (API). It details their manufacturing capabilities, regulatory compliance, and typical production scales relevant to pharmaceutical formulation. The analysis focuses on suppliers meeting stringent quality standards for regulated markets.

What are the primary global sources for Fentanyl Hydrochloride API?

The global supply of Fentanyl Hydrochloride API is concentrated among a limited number of manufacturers, primarily located in China and India, with some presence in Europe. These suppliers must adhere to strict Good Manufacturing Practices (GMP) and often hold Certificates of Suitability to the European Pharmacopoeia (CEP) or equivalent regulatory approvals for access to major pharmaceutical markets.

Key suppliers and their characteristics include:

• Hunan Er-Kang Pharmaceutical Co., Ltd. (China): A significant producer of opioid APIs, including Fentanyl Hydrochloride. The company is a publicly listed entity with substantial manufacturing capacity.

  • Production Scale: Typically operates at multi-ton scale annually for its API portfolio.
  • Regulatory Status: Possesses GMP certification and has filed Drug Master Files (DMFs) with regulatory agencies like the U.S. Food and Drug Administration (FDA).
  • Export Markets: Supplies to North America, Europe, and other regulated markets.

• Jiangsu Hengrui Medicine Co., Ltd. (China): Another major pharmaceutical manufacturer in China with a dedicated API division. Hengrui is known for its broad portfolio of APIs and finished dosage forms.

  • Production Scale: Capable of producing Fentanyl Hydrochloride at commercially significant volumes, often in the hundreds of kilograms to low-tonnage quantities per batch.
  • Regulatory Status: Holds numerous international GMP certifications and its APIs are used in products approved by global regulatory bodies.
  • Export Markets: Extensive global reach, including the United States and the European Union.

• Granules India Ltd. (India): A prominent Indian API manufacturer with a diverse product range. Granules has a strong focus on regulated markets and possesses advanced manufacturing and analytical capabilities.

  • Production Scale: Operates large-scale manufacturing facilities capable of producing Fentanyl Hydrochloride to meet global demand, often in the range of hundreds of kilograms to several metric tons per year.
  • Regulatory Status: Holds U.S. FDA, EDQM (European Directorate for the Quality of Medicines & HealthCare), and other international regulatory approvals. It typically maintains CEPs for its opioid APIs.
  • Export Markets: Supplies to over 75 countries, with a significant presence in the US, Europe, and emerging markets.

• Divi's Laboratories Ltd. (India): A leading Indian API manufacturer known for its large-scale production and strong regulatory compliance. Divi's is a significant supplier of custom synthesis and generic APIs.

  • Production Scale: Known for its capacity to produce high-volume APIs, including controlled substances, in multi-ton quantities.
  • Regulatory Status: Consistently passes inspections by major regulatory agencies, including the FDA and EMA. Holds relevant GMP certifications.
  • Export Markets: Global exporter, serving pharmaceutical companies in North America, Europe, and Asia.

• Actavis/Teva Pharmaceuticals (Global/Europe): While primarily a finished dosage form manufacturer, Teva (which acquired Actavis Generics) has internal API manufacturing capabilities and sources APIs globally. Historically, certain European sites may have had capacity or sourcing agreements for Fentanyl Hydrochloride. Specific current API production capacity for Fentanyl Hydrochloride within Teva's integrated network is proprietary but it is a known player in the opioid market.

  • Production Scale: Integrated production capacity varies, but as a global leader, it possesses significant manufacturing infrastructure.
  • Regulatory Status: Adheres to stringent global GMP standards and regulatory requirements for all its pharmaceutical ingredients.
  • Export Markets: Operates in virtually all global pharmaceutical markets.

• Others: Numerous smaller API manufacturers in China and India may produce Fentanyl Hydrochloride, often for less regulated markets or as intermediaries. However, for access to the U.S., EU, and other highly regulated markets, the suppliers listed above are typically primary sources due to their established regulatory track records and scale.

Table 1: Comparative Analysis of Fentanyl Hydrochloride API Suppliers

Supplier Name	Primary Location	Typical Annual Production Capacity (Fentanyl HCl)	Key Regulatory Approvals (Examples)	Notes
Hunan Er-Kang Pharmaceutical Co., Ltd.	China	Multi-ton	U.S. FDA DMF, China NMPA	Specializes in opioid APIs, significant global exporter.
Jiangsu Hengrui Medicine Co., Ltd.	China	Hundreds of kg to low tons	U.S. FDA, EMA	Broad API portfolio, significant R&D investment.
Granules India Ltd.	India	Hundreds of kg to several metric tons	U.S. FDA, EDQM (CEP), EU GMP	Strong focus on regulated markets, advanced analytical capabilities.
Divi's Laboratories Ltd.	India	Multi-ton	U.S. FDA, EMA	Large-scale generic API production, consistent regulatory compliance.
Teva Pharmaceuticals (integrated)	Global	Proprietary (significant)	U.S. FDA, EMA, PMDA (Japan)	Vertically integrated manufacturer, may source or produce internally. Focus on finished dosage forms.

What are the key regulatory considerations for sourcing Fentanyl Hydrochloride API?

Sourcing Fentanyl Hydrochloride API involves navigating complex international and national regulations due to its classification as a Schedule II controlled substance in the United States and similar controls in other jurisdictions. Key considerations include:

• Drug Master Files (DMFs) / Active Substance Master Files (ASMFs): Suppliers must have robust DMFs or ASMFs filed with regulatory authorities like the U.S. FDA or the European Medicines Agency (EMA). These filings provide confidential detailed information about the manufacturing process, facilities, quality control, and stability of the API. Pharmaceutical companies reference these filings in their drug product applications.
• Good Manufacturing Practices (GMP): API manufacturers must demonstrate compliance with cGMP (current Good Manufacturing Practices). This involves rigorous quality control systems, process validation, impurity profiling, and robust documentation. Regular audits by regulatory agencies and customers are standard.
• Controlled Substance Registrations: Manufacturers and distributors of Fentanyl Hydrochloride API must be registered with national drug enforcement agencies (e.g., the U.S. Drug Enforcement Administration - DEA). This registration dictates quotas, security measures, record-keeping, and reporting requirements for the handling of controlled substances.
• International Narcotics Control Board (INCB) Quotas: For international trade, suppliers and their importing customers must comply with INCB regulations and national import/export licensing requirements to ensure that quantities do not exceed estimated legitimate medical and scientific needs.
• Certificates of Suitability (CEP): For European markets, a CEP issued by the EDQM is a valuable certification. It demonstrates that the API complies with the requirements of the European Pharmacopoeia monograph, streamlining the regulatory review process for drug product applications.
• Import/Export Licenses: Both the exporting and importing entities require specific licenses from their respective national authorities to legally trade controlled substances.
• Security and Diversion Prevention: Stringent physical security measures at manufacturing sites, secure transportation protocols, and meticulous record-keeping are paramount to prevent diversion of Fentanyl Hydrochloride API into illicit channels. This is a significant focus for regulatory bodies and supply chain partners.
• Audits and Quality Agreements: Pharmaceutical companies typically conduct their own rigorous audits of API suppliers and establish detailed Quality Agreements that outline responsibilities for quality control, change management, and regulatory compliance.

What are the typical quality specifications for Fentanyl Hydrochloride API?

Fentanyl Hydrochloride API must meet stringent quality specifications defined by pharmacopoeial monographs and customer-specific requirements. These specifications ensure the safety, efficacy, and consistency of the final drug product.

Key quality parameters include:

• Appearance: White or almost white crystalline powder.
• Identification:
  • Infrared (IR) Spectroscopy: Must match the reference standard spectrum.
  • High-Performance Liquid Chromatography (HPLC): Retention time of the main peak must correspond to that of the reference standard.
• Assay (Potency): Typically specified as 98.0% to 102.0% on an anhydrous and solvent-free basis, determined by titration or HPLC.
• Water Content: Determined by Karl Fischer titration, usually not exceeding 0.5%.
• Residue on Ignition (Sulfated Ash): Generally limited to a maximum of 0.1%, indicating the level of inorganic impurities.
• Heavy Metals: Limits are typically set at or below 20 ppm (parts per million).
• Related Substances (Impurities): This is a critical parameter and is rigorously controlled. Specifications will include limits for:
  • Specified Impurities: Known process-related impurities or degradation products, each with individual limits (e.g., not more than 0.1%).
  • Unspecified Impurities: Any other individual impurity not specifically identified, with a general limit (e.g., not more than 0.1%).
  • Total Impurities: The sum of all specified and unspecified impurities, with a limit typically not exceeding 0.5% or 1.0%.
  • Key Impurities: Manufacturers must identify and control specific impurities known to be potentially genotoxic or have pharmacological activity.
• Residual Solvents: Limits are set according to ICH Q3C guidelines for solvents used in the manufacturing process. Common solvents like ethanol, isopropanol, and acetone will have specific ppm limits.
• Microbiological Purity: While not always specified for non-sterile APIs, manufacturers must control microbial contamination to prevent issues in downstream processing. For APIs intended for sterile products, microbial limits (e.g., Total Aerobic Microbial Count, Total Yeast and Mold Count) and absence of specified objectionable organisms are required.
• Particle Size Distribution: May be specified for certain applications to ensure consistent dissolution rates and formulation properties in the final dosage form.

Pharmacopoeial standards, such as the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), provide detailed monographs that define these specifications. Manufacturers must demonstrate consistent compliance with these monographs.

What are the challenges and risks associated with sourcing Fentanyl Hydrochloride API?

Sourcing Fentanyl Hydrochloride API presents unique challenges and risks beyond those of typical pharmaceutical ingredients, primarily due to its potent pharmacological activity and controlled substance status.

• Regulatory Scrutiny and Compliance Burden: The stringent and ever-evolving regulatory landscape for controlled substances requires significant investment in compliance infrastructure, documentation, and personnel. Failure to meet these standards can result in severe penalties, including loss of licenses and market access.
• Supply Chain Security and Diversion Risk: Fentanyl and its analogs are highly sought after in illicit drug markets. Ensuring the security of the supply chain from the API manufacturer to the finished drug product site is paramount. Risks include theft, diversion, and counterfeiting. Robust security protocols, background checks, and transparent tracking are essential.
• Geopolitical and Economic Factors: The concentration of API manufacturing in specific regions (e.g., China, India) exposes the supply chain to geopolitical risks, trade disputes, and unexpected disruptions (e.g., pandemics, natural disasters). Economic volatility in these regions can also impact pricing and availability.
• Quota Limitations: National and international bodies impose quotas on the production and import of controlled substances to prevent oversupply and diversion. Pharmaceutical companies may face limitations in obtaining sufficient API to meet market demand, leading to supply shortages.
• Quality Variability and Impurity Control: While reputable suppliers adhere to strict GMP, the potential for quality variability, particularly regarding impurity profiles, exists. Inadequate impurity control can lead to product recalls, regulatory actions, and patient safety concerns. Thorough supplier qualification and ongoing quality monitoring are critical.
• Price Volatility: The market for controlled substance APIs can be subject to price volatility influenced by regulatory changes, raw material costs, and demand fluctuations. Building robust supply agreements with price protection clauses can mitigate this risk.
• Lead Times and Inventory Management: Obtaining Fentanyl Hydrochloride API often involves longer lead times due to regulatory processing, manufacturing schedules, and international shipping. Effective inventory management is crucial to balance availability with the risks of holding controlled substances.
• Ethical Sourcing and Corporate Responsibility: Companies must ensure that their sourcing practices align with ethical standards and corporate responsibility, particularly concerning the controlled use of potent opioids. This includes verifying that the API is destined for legitimate medical and scientific purposes.

Key Takeaways

• Global Fentanyl Hydrochloride API supply is primarily concentrated in China and India, with key manufacturers including Hunan Er-Kang, Jiangsu Hengrui, Granules India, and Divi's Laboratories.
• Regulatory compliance is paramount, requiring adherence to GMP, robust DMF/ASMF filings, controlled substance registrations, and potentially CEPs for European markets.
• Strict quality specifications, particularly for impurities and assay, are defined by pharmacopoeial standards (USP, Ph. Eur.) and are subject to rigorous customer audits.
• Sourcing challenges include high regulatory scrutiny, significant risks of supply chain diversion, geopolitical instability, quota limitations, and the need for stringent quality control.

FAQs

1. What is the typical lead time for procuring Fentanyl Hydrochloride API from a qualified supplier? Lead times can vary significantly but typically range from 3 to 6 months, factoring in manufacturing schedules, quality control release, regulatory documentation, and international shipping, especially considering controlled substance export/import licensing.

2. Can a pharmaceutical company directly import Fentanyl Hydrochloride API without a local manufacturing site? Direct import is possible but requires a registered importer with appropriate DEA (or equivalent national agency) registration, import permits, and strict adherence to all controlled substance regulations for storage and handling. Many companies opt to work with established distributors or toll manufacturers who hold the necessary licenses.

3. Are there any alternative APIs to Fentanyl Hydrochloride for potent pain management that have less stringent regulatory controls? While other potent analgesics exist (e.g., hydromorphone, oxymorphone, sufentanil, remifentanil), they are also controlled substances with significant regulatory oversight, albeit potentially with different scheduling or specific control measures. The fundamental challenges of sourcing potent opioid APIs remain.

4. How do manufacturers manage the risk of diversion for Fentanyl Hydrochloride API? Manufacturers employ multi-layered security protocols including secure storage facilities, controlled access, detailed inventory tracking, background checks for personnel, secure transportation logistics, and close cooperation with regulatory authorities to report any suspicious activities or discrepancies.

5. What is the role of the International Narcotics Control Board (INCB) in the Fentanyl Hydrochloride API supply chain? The INCB monitors and controls international trade in narcotics and psychotropic substances. It sets annual estimates for national requirements and allocates quotas to governments, which in turn license manufacturers and importers. This ensures that the global supply of Fentanyl Hydrochloride remains within legitimate medical and scientific needs and helps prevent diversion.

Citations

[1] United States Drug Enforcement Administration. (n.d.). Schedules of Controlled Substances. Retrieved from [DEA website]

[2] European Medicines Agency. (n.d.). Active Substance Master Files (ASMF). Retrieved from [EMA website]

[3] European Directorate for the Quality of Medicines & HealthCare. (n.d.). Certificate of Suitability (CEP). Retrieved from [EDQM website]

[4] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (1997). Impurities: Guideline for Residual Solvents ICH Q3C(R8).

[5] United States Pharmacopeia. (n.d.). Fentanyl Citrate. In United States Pharmacopeia-National Formulary.

[6] European Pharmacopoeia. (n.d.). Fentanyl Hydrochloride. In European Pharmacopoeia.